Epidermal necrolysis French national diagnosis and care protocol (PNDS; protocole national de diagnostic et de soins)

Cyclosporine for Epidermal Necrolysis: Absence of Beneficial Effect in a Retrospective Cohort of 174 Patients—Exposed/Unexposed and Propensity Score-Matched Analyses

(2018) Florence Poizeau et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

SJS/TEN 2017: Building Multidisciplinary Networks to Drive Science and Translation

(2018) Katie D. White et al.   Journal of Allergy and Clinical Immunology-In Practice

Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016

(2017) Andrew Rhodes et al.   INTENSIVE CARE MEDICINE

Cyclosporine Use in Epidermal Necrolysis Is Associated with an Important Mortality Reduction: Evidence from Three Different Approaches

(2017) Carlos González-Herrada et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Cyclosporine treatment for Stevens-Johnson syndrome/toxic epidermal necrolysis: Retrospective analysis of a cohort treated in a specialized referral center

(2017) Haur Yueh Lee et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Severe cutaneous adverse reactions to drugs

(2017) Tu Anh Duong et al.   LANCET

Mucositis Secondary to Chlamydia pneumoniae Infection: Expanding the Mycoplasma pneumoniae -Induced Rash and Mucositis Concept

(2017) Ander Mayor-Ibarguren et al.   PEDIATRIC DERMATOLOGY

Systemic Immunomodulating Therapies for Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis

(2017) Stefanie Zimmermann et al.   JAMA Dermatology

Collaboration in pharmacovigilance: lamotrigine and fatal severe cutaneous adverse reactions – a review of spontaneous reports

(2017) Neil Brickel et al.   Therapeutics and Clinical Risk Management

Long-term Sequelae of Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis

(2016) C Yang et al.   ACTA DERMATO-VENEREOLOGICA

Major psychological complications and decreased health-related quality of life among survivors of Stevens-Johnson syndrome and toxic epidermal necrolysis

(2016) R.P. Dodiuk-Gad et al.   BRITISH JOURNAL OF DERMATOLOGY

U.K. guidelines for the management of Stevens-Johnson syndrome/toxic epidermal necrolysis in adults 2016

(2016) D. Creamer et al.   BRITISH JOURNAL OF DERMATOLOGY

Acute and Chronic Ophthalmic Involvement in Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis – A Comprehensive Review and Guide to Therapy. II. Ophthalmic Disease

(2016) Sahar Kohanim et al.   Ocular Surface

American Burn Association Practice Guidelines Burn Shock Resuscitation

(2016) Tam N. Pham et al.   Journal of Burn Care & Research

Mycoplasma pneumoniae–induced rash and mucositis as a syndrome distinct from Stevens-Johnson syndrome and erythema multiforme: A systematic review

(2015) Theresa N. Canavan et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Toxidermies

(2015) B. Lebrun-Vignes et al.   REVUE DE MEDECINE INTERNE

Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis

(2015) Emilie Bequignon et al.   JAMA Dermatology

Mortalité du SJS-NET et impact de la ciclosporine : étude rétrospective de 130 patients

(2014) L. Valeyrie-Allanore et al.   ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE

Severe Cutaneous Adverse Reactions to Drugs: From Patients to the National Office for Compensation of Medical Accidents

(2014) Anne Isvy-Joubert et al.   DERMATOLOGY

Prognosis of generalized bullous fixed drug eruption: comparison with Stevens-Johnson syndrome and toxic epidermal necrolysis

(2013) S. Lipowicz et al.   BRITISH JOURNAL OF DERMATOLOGY

Linear IgA bullous dermatosis: comparison between the drug-induced and spontaneous forms

(2013) J. Chanal et al.   BRITISH JOURNAL OF DERMATOLOGY

Acute Respiratory Failure in Patients With Toxic Epidermal Necrolysis

(2013) Nicolas de Prost et al.   CRITICAL CARE MEDICINE

Comprehensive Survival Analysis of a Cohort of Patients with Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis

(2013) Peggy Sekula et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Efficacy of Cyclosporine 0.05% Eye Drops in Stevens Johnson Syndrome with Chronic Dry Eye

(2013) Pinnita Prabhasawat et al.   JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS

The role of prior corticosteroid use on the clinical course of Stevens-Johnson syndrome and toxic epidermal necrolysis: a case-control analysis of patients selected from the multinational EuroSCAR and RegiSCAR studies

(2012) H.Y. Lee et al.   BRITISH JOURNAL OF DERMATOLOGY

A multicentre study to determine the value and safety of drug patch tests for the three main classes of severe cutaneous adverse drug reactions

(2012) A. Barbaud et al.   BRITISH JOURNAL OF DERMATOLOGY

Toxic epidermal necrolysis, DRESS, AGEP: Do overlap cases exist?

(2012) Sophie Bouvresse et al.   Orphanet Journal of Rare Diseases

Prise en charge de la douleur dans le syndrome de Stevens-Johnson/Lyell et les autres dermatoses bulleuses étendues

(2011) L. Valeyrie-Allanore et al.   ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE

Prognostic value of histologic features of toxic epidermal necrolysis

(2011) Laurence Valeyrie-Allanore et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Toxic epidermal necrolysis and Stevens-Johnson syndrome

(2011) Thomas Harr et al.   Orphanet Journal of Rare Diseases

Statistical Analysis of Stevens-Johnson Syndrome Caused by Mycoplasma pneumonia Infection in Japan

(2011) Yuko Kunimi et al.   ALLERGOLOGY INTERNATIONAL

Ophthalmic Manifestations of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis and Relation to SCORTEN

(2010) Marlene E. Morales et al.   AMERICAN JOURNAL OF OPHTHALMOLOGY

Open trial of ciclosporin treatment for Stevens-Johnson syndrome and toxic epidermal necrolysis

(2010) L. Valeyrie-Allanore et al.   BRITISH JOURNAL OF DERMATOLOGY

ALDEN, an Algorithm for Assessment of Drug Causality in Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis: Comparison With Case–Control Analysis

(2010) B Sassolas et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Bacteremia in Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis

(2010) Nicolas de Prost et al.   MEDICINE

Vision-Related Function After Scleral Lens Fitting in Ocular Complications of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis

(2009) Bénédicte Tougeron-Brousseau et al.   AMERICAN JOURNAL OF OPHTHALMOLOGY

Severe and Unrecognized Dental Abnormalities After Drug-Induced Epidermal Necrolysis

(2009) Fréderick Gaultier et al.   ARCHIVES OF DERMATOLOGY

Toxic Epidermal Necrolysis Clinical Guidelines

(2009) Frederick W. Endorf et al.   Journal of Burn Care & Research

Antishear Therapy for Toxic Epidermal Necrolysis: An Alternative Treatment Approach

(2009) Amir H. Dorafshar et al.   PLASTIC AND RECONSTRUCTIVE SURGERY

Amniotic Membrane Transplantation as a New Therapy for the Acute Ocular Manifestations of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis

(2009) Elizabeth Shay et al.   SURVEY OF OPHTHALMOLOGY

Toxic epidermal necrolysis: Use of Biobrane® for skin coverage reduces pain, improves mobilisation and decreases infection in elderly patients

(2007) P. Boorboor et al.   BURNS

Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis: Assessment of Medication Risks with Emphasis on Recently Marketed Drugs. The EuroSCAR-Study

(2007) Maja Mockenhaupt et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY